Boston Children’s Hospital Answers article on new research from the labs of Basil Darras and colleagues showing that the oral drug Risdiplam improves motor function in infants, including the ability to sit unassisted for a period of time. They were also more likely than the controls to achieve motor milestones and lived longer than would be expected.